Literature DB >> 18333965

Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein.

Steven L Senior1, Natalia Ninkina, Robert Deacon, David Bannerman, Vladimir L Buchman, Stephanie J Cragg, Richard Wade-Martins.   

Abstract

Alpha-synuclein is intimately involved in the pathogenesis of Parkinson's disease, and has been implicated in the regulation of synthesis, release and reuptake of dopamine (DA). However, mice lacking members of the synuclein family have been reported to display no overt behavioural phenotype. This may be a result of compensatory upregulation of other synucleins during development. Here we report on behaviour and DA synapse function of alpha-synuclein null, gamma-synuclein null, and alpha-gamma-synuclein double-null knockout mice. Double-null mice were hyperactive in a novel environment and alternated at a lower rate in a T-maze spontaneous alternation task, a phenotype reminiscent of mice expressing reduced levels of the DA transporter. To investigate a possible hyperdopaminergic phenotype in alpha-gamma-synuclein double-null mice, we used fast-scan cyclic voltammetry at carbon-fibre microelectrodes to assess DA release and reuptake in striatal slices from wild-type, alpha-null, gamma-null and double-null mice in real time. Double-null mice were found to have a twofold increase in the extracellular concentration of DA detected after discrete electrical stimuli in the striatum. By measuring the rate of reuptake of DA and tissue DA content in these animals, we showed that the observed increase in size of striatal DA transients was not attributable to a decrease in reuptake of DA via the DA transporter, and can not be attributed to an increase in tissue DA levels in the striatum. Rather, we propose that loss of both alpha- and gamma-synuclein causes an increase in release probability from dopaminergic synapses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18333965      PMCID: PMC3145106          DOI: 10.1111/j.1460-9568.2008.06055.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  59 in total

1.  Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.

Authors:  F J Lee; F Liu; Z B Pristupa; H B Niznik
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

2.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

3.  Lipid rafts mediate the synaptic localization of alpha-synuclein.

Authors:  Doris L Fortin; Matthew D Troyer; Ken Nakamura; Shin-ichiro Kubo; Malcolm D Anthony; Robert H Edwards
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

4.  Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain.

Authors:  S Totterdell; G E Meredith
Journal:  Neuroscience       Date:  2005-08-19       Impact factor: 3.590

5.  Attenuation of dopamine transporter activity by alpha-synuclein.

Authors:  Christophe Wersinger; Anita Sidhu
Journal:  Neurosci Lett       Date:  2003-04-17       Impact factor: 3.046

6.  A role for alpha-synuclein in the regulation of dopamine biosynthesis.

Authors:  Ruth G Perez; Jack C Waymire; Eva Lin; Jen J Liu; Fengli Guo; Michael J Zigmond
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

7.  Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS.

Authors:  J -Y Li; P Henning Jensen; A Dahlström
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

8.  Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background.

Authors:  Elise Morice; Cécile Denis; Bruno Giros; Marika Nosten-Bertrand
Journal:  Eur J Neurosci       Date:  2004-07       Impact factor: 3.386

9.  Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism.

Authors:  S B Ross
Journal:  J Neurochem       Date:  1991-01       Impact factor: 5.372

10.  Amphetamine-elicited perseverative and rotational behavior: evaluation of directional preference.

Authors:  L Kokkinidis
Journal:  Pharmacol Biochem Behav       Date:  1987-03       Impact factor: 3.533

View more
  73 in total

1.  Impaired spatial and working memory in ageing mice with targeted inactivation of α-synuclein gene.

Authors:  V S Kokhan; G I Van'kin; N N Ninkina; T A Shelkovnikova; S O Bachurin
Journal:  Dokl Biol Sci       Date:  2012-01-07

Review 2.  GSK-3β activity and hyperdopamine-dependent behaviors.

Authors:  Yan-Chun Li; Wen-Jun Gao
Journal:  Neurosci Biobehav Rev       Date:  2010-08-18       Impact factor: 8.989

Review 3.  The physiological role of α-synuclein and its relationship to Parkinson's Disease.

Authors:  David Sulzer; Robert H Edwards
Journal:  J Neurochem       Date:  2019-07-28       Impact factor: 5.372

Review 4.  The vesicular monoamine transporter 2: an underexplored pharmacological target.

Authors:  Alison I Bernstein; Kristen A Stout; Gary W Miller
Journal:  Neurochem Int       Date:  2014-01-04       Impact factor: 3.921

5.  Alpha-synuclein deletion decreases motor impulsivity but does not affect risky decision making in a mouse Gambling Task.

Authors:  Yolanda Peña-Oliver; Sandra Sanchez-Roige; David N Stephens; Tamzin L Ripley
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

Review 6.  Cell Biology and Pathophysiology of α-Synuclein.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

7.  Showing transmitters the door: synucleins accelerate vesicle release.

Authors:  Dennis J Selkoe
Journal:  Nat Neurosci       Date:  2017-04-25       Impact factor: 24.884

8.  Protein phosphatase 2A is involved in the tyrosine hydroxylase phosphorylation regulated by α-synuclein.

Authors:  Gao Hua; Lan Xiaolei; Yang Weiwei; Wang Hao; Zhu Yuangang; Liu Dongmei; Zhang Yazhuo; Yang Hui
Journal:  Neurochem Res       Date:  2015-01-08       Impact factor: 3.996

9.  A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice.

Authors:  Alexander Kurz; Kay L Double; Isabel Lastres-Becker; Alessandro Tozzi; Michela Tantucci; Vanessa Bockhart; Michael Bonin; Moisés García-Arencibia; Silke Nuber; Falk Schlaudraff; Birgit Liss; Javier Fernández-Ruiz; Manfred Gerlach; Ullrich Wüllner; Hartmut Lüddens; Paolo Calabresi; Georg Auburger; Suzana Gispert
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

10.  Effect of high-fat feeding on expression of genes controlling availability of dopamine in mouse hypothalamus.

Authors:  Alex K Lee; Marjan Mojtahed-Jaberi; Theodosios Kyriakou; Estibaliz Aldecoa-Otalora Astarloa; Matthew Arno; Nichola J Marshall; Susan D Brain; Sandra D O'Dell
Journal:  Nutrition       Date:  2009-10-06       Impact factor: 4.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.